Modulation and personalization of therapy after acute coronary syndromes: the road to precision
Eur Heart J
.
2023 Jun 9;44(22):1965-1967.
doi: 10.1093/eurheartj/ehad231.
Authors
Pierre Sabouret
1
2
,
Giuseppe Biondi-Zoccai
3
4
,
Maciej Banach
5
,
Mattia Galli
6
7
Affiliations
1
Heart Institute and Sorbonne University, 47-83 Bd de L'Hôpital, 75013 Paris, France.
2
National College of French Cardiologists, Department of Cardiology, 13 rue Niepce, 75014 Paris, France.
3
Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Piazzale Aldo Moro 5, 00185 Rome, Italy.
4
Mediterranea Cardiocentro, Cardiology Department, Via F. Caracciolo 15, 80122 Napoli, Italy.
5
Department of Preventive Cardiology and Lipidology, Medical University of Lodz (MUL), Rzgowska 281/289, Lodz 93-338, Poland.
6
Universita Cattolica de Sacro Cuore, Largo Agostino Gemelli, 20123 Milano, Italy.
7
Department of Cardiology, Maria Cecilia Hospital, GVM Care & Research, Via Corriera 1, 48033 Cotignola, Italy.
PMID:
37062814
DOI:
10.1093/eurheartj/ehad231
No abstract available
MeSH terms
Acute Coronary Syndrome* / therapy
Humans
Myocardial Infarction*
Platelet Aggregation Inhibitors
Substances
Platelet Aggregation Inhibitors